Page 6 - Read Online

10 Liver transplantation for hepatocellular carcinoma - non-cancer factors and implications for
improving outcome beyond standard tumor criteria
Arno Kornberg, Martina Schernhammer
Hepatoma Res 2018;4:60 http://dx.doi.org/10.20517/2394-5079.2018.86

11 Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver
transplantation
Evangelia M. Fatourou, Abid R. Suddle, Michael A. Heneghan
Hepatoma Res 2018;4:63 http://dx.doi.org/10.20517/2394-5079.2018.62

12 New and old biomarkers of hepatocellular carcinoma
Georgios Zacharakis, Ahmad Aleid, Khaled K Aldossari
Hepatoma Res 2018;4:65 http://dx.doi.org/10.20517/2394-5079.2018.76

13 Minimally invasive therapies for hepatocellular carcinoma: narrowing the gaps
Kevin M. Sullivan, Raymond S. Yeung
Hepatoma Res 2018;4:68 http://dx.doi.org/10.20517/2394-5079.2018.95

14 The prediction of microvascular invasion of hepatocellular carcinoma using multiple imaging
modalities
Hideyuki Tamai
Hepatoma Res 2018;4:75 http://dx.doi.org/10.20517/2394-5079.2018.98

Original Article

15 A potential clinical based score in hepatitis C virus cirrhotic patients to exclude small
hepatocellular carcinoma
Denise Cerqueira Paranaguá-Vezozzo, Celso Eduardo Lourenço Matielo, Daniel Ferraz de Campos
Mazo, Lucas Souto Nacif, Mario Guimaraes Pessoa, Gleicy Luz Reinoso Pereira, Roque Gabriel
Rezende de Lima, Patricia Momoyo Yoshimura Zitelli, Suzane Kioko Ono, Flair José Carrilho
Hepatoma Res 2018;4:11 http://dx.doi.org/10.20517/2394-5079.2018.17

16 Hepatocellular carcinoma in patients without cirrhosis: relevance and clinical characteristics
Kellyane Santana Dias Carvalho, Luciano E. Fonseca, Helma P. Cotrim
Hepatoma Res 2018;4:15 http://dx.doi.org/10.20517/2394-5079.2018.13

17 Adult African Americans undergoing cadaveric liver transplantation for hepatocellular
carcinoma within the Milan criteria have the lowest 5-year survival among all the ethnic groups
in the United States: analysis of USA national data between January 2002 and June 2013
Michele Molinari, Subhashini Ayloo, Allan Tsung, Patrick Bou Samra, Naudia Jonaissaint
Hepatoma Res 2018;4:56 http://dx.doi.org/10.20517/2394-5079.2018.71

18 Novel diagnosis and therapy for hepatoma targeting HBV-related carcinogenesis through
alternative splicing of FIR (PUF60)/FIRΔexon2
Kazuyuki Matsushita, Tyuji Hoshino
Hepatoma Res 2018;4:61 http://dx.doi.org/10.20517/2394-5079.2018.81